Log In
Print
BCIQ
Print
Print this Print this
 

edivoxetine (LY2216684)

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionSelective norepinephrine reuptake inhibitor
Molecular Target Norepinephrine transporter
Mechanism of ActionNorepinephrine reuptake inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II/III
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat attention deficit hyperactivity disorder (ADHD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today